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Background: The knowledge of scientific dishonesty is scarce and heterogeneous. Therefore this study investigates
the experiences with and the attitudes towards various forms of scientific dishonesty among PhD-students at the
medical faculties of all Norwegian universities.
Method: Anonymous questionnaire distributed to all post graduate students attending introductory PhD-courses at
all medical faculties in Norway in 2010/2011. Descriptive statistics.
Results: 189 of 262 questionnaires were returned (72.1%). 65% of the respondents had not, during the last year,
heard or read about researchers who committed scientific dishonesty. One respondent had experienced pressure to
fabricate and to falsify data, and one had experienced pressure to plagiarize data. On average 60% of the
respondents were uncertain whether their department had a written policy concerning scientific conduct. About
11% of the respondents had experienced unethical pressure concerning the order of authors during the last
12 months. 10% did not find it inappropriate to report experimental data without having conducted the
experiment and 38% did not find it inappropriate to try a variety of different methods of analysis to find a
statistically significant result. 13% agreed that it is acceptable to selectively omit contradictory results to expedite
publication and 10% found it acceptable to falsify or fabricate data to expedite publication, if they were confident
of their findings. 79% agreed that they would be willing to report misconduct to a responsible official.
Conclusion: Although there is less scientific dishonesty reported in Norway than in other countries, dishonesty is
not unknown to doctoral students. Some forms of scientific misconduct are considered to be acceptable by a
significant minority. There was little awareness of relevant policies for scientific conduct, but a high level of
willingness to report misconduct.
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Scientific dishonesty frequently refers to actions or omis-
sions in connection with research, which leads to false
or distorted scientific results or gives misleading infor-
mation about an individual contribution to research
[1-3]. Scientific dishonesty is problematic for a number
of reasons. It may directly or indirectly harm vulnerable
research participants. It may undermine the general trust
in science and scientists, and it may cause harm if future
research or therapy attempts to rely on fraudulent
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research has become international and interdisciplinary,
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cult question with significant methodological challenges
[8], and divergent answers can be found within empirical
research [9-11]. Not surprisingly there seems to be sig-
nificant underreporting of dishonesty and misconduct
[12,13]. A systematic review and meta-analysis [11]
showed that an average of 2% of scientists admitted ser-
ious forms of misconduct (fabrication, falsification or
modification of data or results) at least once. Up to 34%
admitted other questionable research practices, and in
surveys asking about the behaviour of colleagues, ‘admis-
sion’ rates were 14% for falsification, and up to 72% for
other questionable research practices. Medical/pharma-
cological researchers reported misconduct more fre-
quently than others, although not significantly so, and it
is concluded by the author that it is likely that the result
is a conservative estimate of the true prevalence of sci-
entific misconduct [11]. In a Nordic context population
based calculations indicate that Denmark has 1–2 cases/
million inhabitants per year, Finland 1–2 cases/million
per year, and Norway 1 case/million per year [14].
It is argued that there is no clear relationship between
attending courses in research ethics or mentoring and sci-
entific dishonesty. Training has not been shown to be ef-
fective in preventing problematic behaviour, and mentoring
both increased and decreased the likelihood of problematic
behaviours, depending on the kind of mentoring (research,
financial, survival, personal, ethics) [15].
A study of undergraduate and postgraduate pharmacy
students revealed widespread deficiencies in student
knowledge of, and attitudes towards, plagiarism [16].
Many students did not perceive plagiarism as a serious
issue and the use of inappropriate strategies for sourcing
and acknowledging material was common. Similar
results are found elsewhere [17].
Although medical students consider dishonest behav-
iour to be wrong, a substantial number of students re-
port that they engage in dishonest behaviour [17,18].
Students’ attitudes appear to be stable throughout the
years of the study [19], and their willingness to cheat
may be culturally dependent and starts before medical
school [20]. The baseline knowledge of responsible con-
duct of research for biomedical sciences students is
shown to be inadequate and inconsistent [21].
There appear to be several motives for scientific dis-
honesty: the universities’ admission requirements, the
system for financing, access to scholarships [3], and the
perceived need for personal progress and success.
Scientific dishonesty has been studied in the Nordic
countries [22-25], but our knowledge is still limited and
of medium or poor quality. One study has been carried
out in Sweden, [3] but comparative knowledge is neces-
sary to assess the extension of dishonesty and postgradu-
ate students’ attitudes towards scientific dishonesty.What are PhD-students experiences with scientific dis-
honesty, what are their attitudes towards various forms
of scientific dishonesty, and what do they know about
regulations and policies? These are the key questions of
our survey carried out among PhD-students at medical
faculties in Norway.
Methods
A two-page questionnaire combining a survey developed
at the Department of Medical Ethics in Lund, Sweden
[3] with a survey developed by Kalichman was applied
[9,26]. Terms such as ‘scientific dishonesty’, ‘plagiarism’,
‘fabrication of data’, and ‘falsification’ were given stand-
ard definitions in the introduction. The questionnaire
was piloted with a group of students similar to the
intended respondents, and a few ambiguous statements
were identified and re-written.
The participants in the study were post-graduate stu-
dents being enrolled in PhD-programs at all medical fac-
ulties in Norway, i.e., at the universities in Oslo, Bergen,
Trondheim, and Tromsø. The questionnaires were dis-
tributed to doctoral students attending basic, obligatory
courses in research methodology, philosophy of science,
and research ethics at the four medical faculties in Nor-
way in the fall 2010 and in the winter 2011 in Tromsø
and Trondheim. There were two courses in Oslo in the
fall 2010, one of the courses was held in Norwegian
(Oslo 1) and one in English (Oslo 2). The questionnaires
were anonymous and participation was voluntary. The
questionnaires were distributed and collected before any
discussion of scientific misconduct had taken place in
the course. Answer categories were Yes/No/Uncertain,
and Strongly Disagree/Disagree/Neither Agree nor Dis-
agree/Agree/Strongly Agree.
Descriptive statistics was used to find differences in
post graduate students’ attitudes towards and experi-
ences with scientific dishonesty. Categorical variables
were compared using the Student t test, Fisher exact test,
Mann–Whitney test (p < 0.05 was considered significant).
Answers were not traceable to participants. The pro-
ject is registered at the Norwegian Social Science Data
Service, overseeing privacy and data protection accord-
ing to the Personal Data Act.
Results
The total number of questionnaires distributed and
returned at the various universities, together with the
participants’ answers to questions about academic back-
ground is displayed in Table 1. 262 questionnaires were
distributed, of which 189 were returned, giving an over-
all response rate of 72.1%. The doctoral candidates’
voluntary participation and anonymity were emphasised
in the covering letter and when handing out the
questionnaires.
Table 1 Total number of questionnaires distributed and returned, together with the participants’ answers to questions
about academic background
Site: Questions Bergen Oslo 1 Oslo 2 Tromsø Trondheim All in Norway All in
Sweden
Returned/distributed (n) 38/56 47/48 31/39† 32/39 41/80 189/262 134/230
Response rate (%) 67,9 97,9 79,5 82,1 51,3 72,1 58,3
Undergraduate studies in Norway n (%) 27 (71) 39 (83) 15 (47) 25 (78) 31 (76) 137 (72) -
Doing Clinical/Basic/Other research 20/11/6 24/12/10 7/18/6 14/8/10 20/5/16 85/54/48 -
Years of experience: <1yr/1-2yrs/>2yrs 23/11/4 34/9/4 17/8/6 11/15/6 33/7/1 118/50/21 -
Lectures or courses in science ethics as part of
undergraduate studies (Yes/No/I do not remember)
21/12/5 31/11/5 25/4/2 22/7/3 25/12/4 124/66/20 -
Obligatory course (Yes/No) YES YES YES YES YES 262/262‡ 128/6
Obligatory exam (Yes/No) YES YES YES YES YES 262/262 91/43
Data from Sweden reproduced from Nilstun 2010.
†One was returned blank (and is not counted in the response rate as it does not contribute with information).
‡The doctoral courses covering science ethics were obligatory at all universities in Norway, but the participation in the teaching every day was not obligatory.
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Norwegian universities—from about 51% (Trondheim)
to 98% (Oslo). Most of the respondents had taken their
undergraduate studies in Norway (72%), except for the
course in Oslo given in English (Oslo 2) where 53% of
the respondents had taken their undergraduate studies
outside of Norway.
The largest group of respondents were doing clinical
research (45%), and 29% were doing basic research. 62%
and 11% of the respondents had been a doctoral student
less than one year and more than two years respectively.
On average, the respondents in Tromsø had been doc-
toral students longer compared to respondents from the
other universities.
59% of the respondents had attended lectures or
courses in science ethics as part of their undergraduate
studies while 31% had not.
The pilot study was carried out in Oslo including 26
respondents with a response rate of 55,3%.
To the questions about the experience of scientific dis-
honesty and other unethical behaviour in connection
with research during the previous 12 months, on average
23% of the respondents answered that they had heard or
read about researchers who had cheated (nationally or
internationally), 65% had not heard about this, and 12%
were uncertain. 29% had heard about fabricated data
(see Table 2).
One respondent had experienced pressure to fabricate
and to falsify data, and one had experienced pressure to
plagiarize data, while none of the participants had felt
pressure to plagiarize publications. Five respondents
were uncertain if they had experienced pressure to fabri-
cate data.
None of the respondents reported to have fabricated,
falsified or plagiarized data or to have plagiarized publi-
cations. Only one respondent was uncertain whether heor she had plagiarized data and two were uncertain
whether they had plagiarized publications.
About 11% of the respondents had experienced uneth-
ical pressure concerning the order of authors on publi-
cations during the last 12 months. In addition 7% stated
that they didn’t know whether they have experienced
such pressure. Five respondents had experienced uneth-
ical pressure concerning design/method and five had
experienced unethical pressure concerning results, while
one had experienced harassment.
About 6% of the respondents had been affected by eth-
ical consequences of scientific dishonesty, and 3% had
been affected by methodological consequences of scien-
tific dishonesty during the last 12 months.
60% of the respondents were uncertain whether their
department had a written policy about scientific con-
duct. 28% stated that their department had a written
policy, and 12% that their department did not. Written
policies on funding and on fabrication and falsification
of data reached the highest reported awareness amongst
the respondents (38%, 31%, and 31%). See Table 3.
The results on attitudes towards scientific misconduct
(Table 4) show that 10% did not agree with the state-
ment that it was never appropriate to report experimen-
tal data that have been created without actually having
conducted the experiment, and 4% did not agree that it
is never appropriate to alter experimental data to make
an experiment look better than it actually was.
38% did not agree with the statement that it is never
appropriate to try a variety of different methods of ana-
lysis until one is found that yields a result that is statisti-
cally significant, and 5% did not agree that it is never
appropriate to take credit for the words or writing of
someone else.
12% did not agree that it is never appropriate to take
credit for data generated by someone else, and 8% did
Table 2 Answers to questions about scientific dishonesty and other unethical behaviour in connection with research
(Those who have answered YES in percent)
Questions Bergen Oslo 1 Oslo 2 Tromsø Trondheim All Norway All Sweden
Have you, nationally or internationally, heard about anyone who during the last 12 months that has
Fabricated data 21,1 28,3 33,3 36,7 29,3 29,2 29
Falsified data 18,4 23,9 23,3 30 24,4 23,8 31,8
Plagiarised data 13,2 19,6 20 23,3 29,3 21,1 24,2
Plagiarised publications 5,3 17,4 16,1 31,3 29,3 19,7 -
Have you yourself during the last 12 months been the object of pressure to
Fabricate data 0 2,1 0 0 0 0,5 0
Falsify data 0 2,1 0 0 0 0,5 5,4
Plagiarise data 0 0 3,2 0 0 0,5 0
Plagiarise publications 0 0 0 0 0 0 -
Have you during the last 12 months been exposed to unethical pressure concerning
Ordering of authors 13,2 8,7 12,9 12,5 7,3 10,6 8,5
Design/method 0 2,2 6,5 3,1 2,4 2,7 3,1
Results 0 0 12,9 0 2,4 2,7 0,8
Harassment 0 0 0 3,1 0 0,5 0,8
Have you during the last 12 months been affected by any consequences of scientific dishonesty
Ethical 0 6,5 3,2 12,5 7,3 5,9 0
Legal 0 0 3,2 3,1 0 1,1 0
Methodological 0 4,3 0 3,1 7,3 3,2 -
Any other aspect 2,6 4,3 3,2 0 4,9 3,2 0
Data from Sweden reproduced from Nilstun 2010.
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the ideas generated by someone else.
13% agreed that it is acceptable to selectively omit
contradictory results to expedite publication and 10%
found it acceptable to falsify or fabricate data to expedite
publication, if they were confident of their findings, and
29% agreed that it is more important that data reportingTable 3 How many PhD-students were uncertain about wheth
Questions Bergen Oslo 1 Oslo 2
Does your department have a written policy about
Application for funds 63,9 44,7 48,4
Use of funds 63,9 36,2 41,9
Changes in design/method 72,2 63,8 61,3
Changes in results 77,8 59,6 71
Fabrication of data 75 38,3 48,4
Falsification of data 75 38,3 48,4
Ordering of authors 72,2 38,3 54,8
Plagiarism of others 75 46,8 48,4
Publishing the same twice 77,8 44,7 61,3
Harassment 83,3 53,2 41,9
Data from Sweden reproduced from [3].be completely truthful in a publication than in a grant
application. 13% agreed that you have an ethical obliga-
tion to act if you witness someone committing research
misconduct.
79% agreed they would be willing to report that mis-
conduct to a responsible official, if they had witnessed a
co-worker or peer committing research misconduct, ander their department had written policies (in percent)
Tromsø Trondheim All Norway All Sweden
62,5 53,7 54 59,2
65,6 61 52,9 57,7
77,4 68,3 68,3 47,3
77,4 65,9 69,4 43,1
71 61 57,5 44,6
71 61 57,5 43,8
75 63,4 59,4 50,8
71,9 53,7 58,3 49,6
75 61 62,6 46,2
68,8 65,9 62,6 43,8
Table 4 Proportion who answer that they strongly agree or agree with claims about actions and behavior in scientific
research given in percent
Questions Bergen Oslo 1 Oslo 2 Tromsø Trondheim All
Norway
It is never appropriate to report experimental data that have been created without
actually having conducted the experiment.
94,7 91,1 83,3 93,8 87,5 90,3
It is never appropriate to alter experimental data to make an experiment look better
than it actually was.
100 93,5 90,3 100 97,5 96,3
It is never appropriate to try a variety of different methods of analysis until one is found
that yields a result that is statistically significant.
68,4 47,8 51,6 73,3 71,8 62
It is never appropriate to take credit for the words or writing of someone else. 91,9 91,3 96,8 100 97,5 95,2
It is never appropriate to take credit for the data generated by someone else. 81,6 82,2 90,3 93,5 95 88,1
It is never appropriate to take credit for the ideas generated by someone else. 92,1 84,4 96,7 96,9 92,3 91,8
If you were confident of your findings, it is acceptable to selectively omit contradictory
results to expedite publication.
8,1 14,3 23,3 12,9 7,7 12,8
If you were confident of your findings, it is acceptable to falsify or fabricate data to
expedite publication.
2,6 17,8 6,5 13,3 10 10,3
It is more important that data reporting be completely truthful in a publication than in
a grant application.
28,9 38,6 30 36,7 12,8 29,3
If you witness someone committing research misconduct, you have an ethical
obligation to act.
81,6 80,4 96,8 87,1 92,5 87,1
If you had witnessed a co-worker or peer committing research misconduct, you would
be willing to report that misconduct to a responsible official.
78,9 78,3 80,6 80,6 77,5 79
If you had witnessed a supervisor or principal investigator committing research
misconduct, you would be willing to report that misconduct to a responsible official.
71,1 75,6 80 67,7 77,5 74,5
If fabricated data are discovered in a published paper, all co-authors must equally share
in the blame.
60,5 28,3 51,6 48,4 45 45,7
If fabricated data are discovered in a published paper, all co-authors must receive the
same punishment.
39,5 15,2 38,7 30 25,6 28,8
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to a responsible official if they had witnessed a supervisor
or principal investigator committing research misconduct.
46% agreed that all co-authors must equally share in
the blame if fabricated data are discovered in a published
paper, and 29% agreed that all co-authors must receive
the same punishment if fabricated data are discovered in
a published paper.
There were some differences between the universities.
E.g., only half of the PhD-students in Oslo disagreed that
it was never appropriate to try a variety of different
methods of analysis until one is found that yields a result
that is statistically significant. More PhD-students at the
course in English in Oslo (Oslo 2) than the average
found it acceptable to selectively omit contradictory
results to expedite publication if they were confident of
their findings. Fewer PhD-students at Oslo 1 and more
in Bergen agreed that all co-authors must equally share
in the blame if fabricated data are discovered in a pub-
lished paper than the average. Fewer of the PhD-
students in Trondheim agreed that it is more important
that data reporting be completely truthful in a publica-
tion than in a grant application than the average. In
Tromsø fewer respondents than the average reportedthat it is never appropriate to try a variety of different
methods of analysis until one is found that yields a result
that is statistically significant. More PhD-students with
undergraduate studies outside Norway answered that
they had been exposed to unethical pressure concerning
results during the last 12 months than those who had
studied in Norway (p = 0.045, Fischer’s exact test), and
that they were uncertain whether they had been exposed
to unethical pressure concerning harassment (p = 0.02,
Fischer’s exact test). The PhD-students with undergradu-
ate studies outside Norway differed also from those that
had studied in Norway in that they found it more ac-
ceptable to selectively omit contradictory results to ex-
pedite publication if they were confident of their
findings (p = 0.008, Mann–Whitney).Discussion
The findings show that scientific dishonesty is not un-
known to Norwegian doctoral students and that they
found some actions acceptable which are considered to
be misconduct in the science ethics literature. There was
little awareness of relevant policies for scientific conduct,
but a high level of willingness to report misconduct.
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Many of the respondents were unaware of their depart-
ments’ policies concerning scientific conduct. The rea-
son for this may be due to organizational distances
between science ethics policy makers and researchers
(and perhaps even more research students), and indi-
cates that communication about such policies needs to
be improved and implemented better in order to work
as intended. Another reason may be that many scientists
are uncomfortable to talk about research misconduct
and reluctant to act when they see it [27]. If this is so,
there is an urgent need to enhance awareness, proce-
dures and measures [28]. Moreover, as recognized by
Nilstun [3], there are two interpretations of those doc-
toral students who were uncertain about whether there
existed a policy at their department: “The first interpret-
ation is that the respondents are certain that a policy
exists, but they are uncertain about what it prescribes.
The second interpretation is that the respondents are
uncertain as to whether or not a policy exists at all”. As
Nilstun and colleagues point out, both interpretations
raise challenges to present policies.
The Sudbø case can explain the difference between
the results in Norway and Sweden. Moreover, the Uni-
versity of Oslo elaborated and put great emphasis on
ethical guidelines at all of its faculties. This was not done
in the same manner at the other universities in Norway,
who do not have specific guidelines or policies, but who
refer to national legislation.Pressure and reporting
About 11% of the respondents in Norway had experi-
enced unethical pressure concerning the order of
authors. In addition 7% answered that they don’t
know whether they have experienced unethical pres-
sure concerning the order of authors. It may well be
that these 7% have experienced some kind of pres-
sure, but were unsure whether this experience quali-
fied for the label “unethical” or not. If you haven’t
experienced the order of authors as an issue at all,
then you would probably answer “No” rather than
“Don’t know”. Combined this means as much as 18%
may have experienced unethical pressure concerning
the order of authors.
The results also show that a considerable number of
PhD-students experience pressure towards other kinds
of scientific dishonesty, which is worrying. It indicates
that scientific dishonesty has to be further addressed at
an organizational level and not only at the level of the
individual researcher [17].
More positive is that most participants state that
they would report scientific misconduct if they experi-
enced it.Comparison with other surveys
Our results are in accordance with the results from the
Swedish study [3]. This may be because the cultural dif-
ferences between the Scandinavian countries are small,
because there is extensive scientific collaboration and
exchange between the countries, and because the educa-
tional system is similar. The results tentatively indicate
less scientific dishonesty in Norway than in other coun-
tries [9,11]. This counters previous results from Norway,
showing that 22% of 274 medical scientists knew about
cases of serious misconduct, 9% had themselves contrib-
uted to one or more incidents of misconduct, and 3% of
the respondents were aware of falsification or fabrication
of data [29]. However, the Swedish and our survey asked
about scientific dishonesty specifically within the last 12
months, whereas other studies were less specific and did
not have this time restraint. If respondents have
answered with a view to the last 12 months in our study
(and in the study of Nilstun et al.) then our results
should be expected to be lower than in studies reporting
what is essentially a life time prevalence rate, which
from a scientist’s perspective is considerably more than
12 months.
No participants in this study reported that they had
fabricated, falsified or plagiarized data or plagiarized
publications, while four persons in the Swedish survey
reported fabrication or falsification of data [3]. However,
three persons in the Norwegian study were uncertain
whether they had plagiarized data or publications (com-
pared to three persons who were uncertain about pla-
giarizing data in the Swedish survey). The low rates are
in line with previous studies [30,31], but it may of course
be that participants are cautious concerning reporting
scientific dishonesty to a study performed by researchers
at their faculty who teach science ethics, even when the
answers are anonymous. Hence, the method may not be
adequate to reveal scientific dishonesty, or the presup-
position that we only discover the top of the iceberg [27]
may be wrong. However, the low rates and the ‘unsure’
answers to whether respondents had falsified or plagi-
arised data fits well with a lax conception of scientific
dishonesty. People with a lax conception of falsification
or plagiarism, will not report to have falsified or plagiar-
ized data in the same situation where others would have
reported to have done so or that they were unsure.
When comparing with other countries it is also worth
noting that the Nordic countries define scientific dishon-
esty slightly differently [23]. The current Swedish guide-
lines for judging alleged scientific fraud state that the
state of affairs—not the intention—is important [32]
whereas intentions are relevant in Norway, e.g., for the
assessment of the severity of the misconduct [31].
Although results from studies with undergraduate stu-
dents from various parts of the world are relevant [33-35],
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PhD-students.
Types of misconduct
A relatively large proportion of the respondents found
some actions acceptable which are considered to be mis-
conduct in the science ethics literature. E.g., responses
from 11 of the 189 respondents (5,8%) indicate that they
think it can be appropriate to report experimental data
that have been created without actually having con-
ducted the experiment and 20 respondents (10,6%) indi-
cated that it is appropriate to try a variety of different
methods of analysis until one is found that yields a result
that is statistically significant. 23 participants (12,2%)
agreed that it is acceptable to selectively omit contradict-
ory results to expedite publication and 19 (10,1%) found
it acceptable to falsify or fabricate data to expedite publi-
cation, if they were confident of their findings. This cor-
responds with other studies [6,7,15].
At the same time most of the participants would re-
port research misconduct if they witnessed it, even if it
was committed by the principal investigator or their
supervisor. Whether they would do so in actual cases,
we do not know, but it is interesting that the respon-
dents appear to have rather lax conceptions of scientific
misconduct, but that they are willing to report it if they
saw it. The reason for this may be that revealing mis-
conduct, such as in the Sudbø case, can be meriting.
There is hence no necessary connection between will-
ingness to report misconduct and a strict conception of
misconduct.
In Norway about 6% of the respondents had been
affected by ethical consequences of scientific dishonesty,
and 3% by methodological consequences of scientific
dishonesty in the last 12 months, compared to none in
Sweden. The reason for this may be that some large re-
search projects in Norway were stopped or altered re-
cently due to scientific dishonesty, which had severe
consequences for the PhD-students on these projects.
The results underscore the necessity for efficient mea-
sures to reduce misconduct. However, the effectiveness
of the organisational procedures for reducing miscon-
duct has been reported to be lower in medical centres
than in other settings [36]. Training and attending
courses may not be the only or the best way to go [8].
Supervisors and principal investigators may need more
awareness [6,37], as higher incidents of misconduct has
been observed among mid-career scientists who often
are supervisors for PhD candidates.
Methodological limitations
There are methodological limitations in relation to the
questionnaire. No validated questionnaires were avail-
able, but a questionnaire that had previously beenapplied (and published) was used in order to enable
direct comparison. The face validity of the Swedish
questionnaire was tested and our pilot study resulted
in an improved survey introduction and some add-
itional questions. Ideally we would have made a more
thorough validation of the questionnaire and its reli-
ability, for instance through a test re-test procedure.
However, the setting with the PhD-courses does not
easily permit this. It appears to be an advantage to our
study that we compare the respondents’ reported
actions with their attitudes as which was not done in
the Swedish study. The response rate in our study is
higher than in the Swedish study (71.2% versus 58%).
We obtained the highest response rate when time was
allocated to filling in the form. Longer time between
handing out and handing in the form resulted in lower
response rate.
Although there are reasons to believe that at least
some PhD-students have cheated before (during their
undergraduate studies), there appear to be cultural dif-
ferences in attitudes to teaching [20]. For example it has
been reported that at the University of Oslo several of
the students at previous PhD-courses have been caught
in copying at exams (even when signing a written state-
ment concerning referencing and plagiarism) [38]. It
turned out that most of these students were trained in
countries with different scientific norms. Our study did
not reveal great difference between those attending the
English-speaking course and the Norwegian-speaking
course in Oslo (Oslo 1). The only question where there
was a noteworthy difference was whether the respondent
found it acceptable to selectively omit contradictory
results to expedite publication if they were confident of
their findings, where 23% of the participants at the
English-speaking course (Oslo 2) agreed, compared to
14% of the participants at the Norwegian-speaking
course (Oslo 1) and 13% in all Norway.
Although our study showed some substantial differ-
ences between the PhD-students who had their
undergraduate studies in and outside Norway, this is
not beyond what one could expect to find by pure
randomness.
Although it is argued that ethics training and mentor-
ing is not effective in preventing scientific dishonesty
[15], and that dishonesty may be related to personality
traits [39], there is a wide range of strategies to avoid
scientific dishonesty in medical research available [40].
Moreover, important measures to avoid and reveal scien-
tific dishonesty are taken by associations of journals, such
as World Association of Medical Editors (WAME), Council
of Science Editors (CSE), European Association of` Science
Editors (EASE), and Committee on Publication Ethics
(COPE). More research is needed to find the most effective
measures to reduce scientific dishonesty.
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The survey shows that scientific dishonesty is not un-
known to PhD students in Norway. Very few stated that
they were exposed to pressure to fabricate, falsify, or pla-
giarise data, while pressure put upon post graduate stu-
dents regarding the order of authors was more common.
Some forms of scientific misconduct were considered to
be acceptable by a substantial minority. e.g., almost two
of five respondents found data fishing acceptable. There
was little awareness of relevant policies for scientific con-
duct, but a high level of willingness to report misconduct.
With the intention to build more awareness and
improved attitudes towards various forms of scientific
dishonesty our suggestions are:
 Increase the quality of teaching, use cases, focus on
grey areas, and communicate the norms of good
scientific practice repeatedly and in a variety of
settings.
 Provide better training for supervisors and ensure
that they have the appropriate knowledge and
promote attitudes.
 Clarify institutional policies towards scientific
dishonesty and communicate them more effectively.
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